R&D Reimagining women's health in the 21st century Imagine a world where medical research routinely excluded men... That's the reality many women face when it comes to healthcare.
News Hengrui to file obesity shot in China after phase 3 win An obesity therapy developed Hengrui Pharma and Kailera is being prepared for its first regulatory submission, in China.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
